NICOLE SANDILANDS: Open Payments
NPI 1245853787 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 26 payments from 12 companies in 2025. Trend: 2023 $1,546 · 2024 $4,347 · 2025 $2,459
Speaker / faculty: $1,800Food & beverage: $636Education: $23
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $2,016 |
| Gilead Sciences, Inc. | 6 | $142 |
| Daiichi Sankyo Inc. | 4 | $79 |
| Janssen Biotech, Inc. | 1 | $35 |
| Genentech USA, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $21 |
Products named: DATROWAY, Trodelvy, Enhertu, DARZALEX, Itovebi, KISQALI, KEYTRUDA, VERZENIO.
Industry payments across CT — which companies pay providers there.
